Market Data 
Markets
Replies to post #659611 on NorthWest Biotherapeutics Inc (NWBO)
The CHM meeting doesn't always mandate further review of the MHRA's MAA review. However, the CHM meeting serves as a crucial step in the evaluation process, offering a platform for in-depth discussions among experts from various EU member states, (but also) including the UK's MHRA (which is no longer in the EU). Their discussions and recommendations can influence the final decision regarding the authorization of a medicinal product, but it doesn't automatically trigger a requirement for additional review by the MHRA specifically.
AI
